Close Menu

Amphastar Pharmaceuticals hired a private detective firm to poke around in the lives of both Janet Woodcock, the director of FDA's Center for Drug Evaluation and Research, and Moheb Nasr, who is in charge of the Office of New Drug Quality Assessment, Politico reports. The company says it wanted to determine whether the officials were favoring its competitor, Momenta. The investigative firm Kroll, Politico reports, came up empty.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Washington Post reports on researchers' efforts to determine the effect of an increasingly common SARS-CoV-2 mutation.

Florida Politics reports Florida's law barring life, long-term care, and disability insurers from using genetic information in coverage decisions went into effect at the beginning of July.

A new analysis finds a link between popular media coverage of a scientific study and how often that paper is cited.

In Nature this week: CRISPR approaches to editing plant genomes, way to speed up DNA-PAINT, and more.